SCHEMBL22454432

SCHEMBL22454432

COc1cc2ncnc(Oc3ccc(NC(=O)N4CCCC4)cc3)c2cc1OC

nearest known ligand 0.72

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.72
PDGFRA P16234 4/20 0.70
PDGFRB P09619 10/20 0.68
CSF1R P07333 1/20 0.68
KIT P10721 2/20 0.67
FGFR1 P11362 1/20 0.67
FGFR2 P21802 1/20 0.67
FGFR4 P22455 1/20 0.67
FGFR3 P22607 1/20 0.67
FLT3 P36888 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22454334 0.99 KDR (0.70) KDRPDGFRAPDGFRBCSF1RKIT
SCHEMBL5825213 0.88 PDGFRB (0.76) KDRPDGFRAPDGFRBCSF1RKIT
SCHEMBL5825206 0.86 PDGFRB (0.67) KDRPDGFRAPDGFRBCSF1RKIT
SCHEMBL5824465 0.85 KDR (0.73) KDRPDGFRAPDGFRBCSF1RKIT
SCHEMBL5824658 0.85 KDR (0.73) KDRPDGFRAPDGFRBCSF1RKIT
SCHEMBL6009208 0.84 KDR (0.83) KDRPDGFRAPDGFRBCSF1RKIT
SCHEMBL7480612 0.83 KDR (1.00) KDRPDGFRAPDGFRBCSF1RKIT
SCHEMBL5824362 0.83 KDR (0.81) KDRPDGFRAPDGFRBCSF1RKIT
SCHEMBL5824681 0.82 KDR (0.73) KDRPDGFRACSF1RKIT
SCHEMBL24358871 0.82 KDR (0.85) KDRPDGFRAPDGFRBCSF1RKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3929182-A1 MULTI-TARGET KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF Guangzhou Liushun Biotechnology Co., Ltd. (CN) 2021-12-29 EP disclosed
WO-2020186812-A1 MULTI-TARGET KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF 广州六顺生物科技股份有限公司 2020-09-24 WO disclosed